Skip to main content
logo
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.5900
-0.0100 (-1.67%)
At close: Aug 12, 2026, 4:00 PM EDT
0.6400
+0.0500 (8.47%)
After-hours: Aug 12, 2026, 7:37 PM EDT

RedHill Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.290.29--61.885.76
Revenue Growth
-81.02%----27.94%33.25%
Gross Profit
2.470.29--28.4636.35
Operating Income
7.947.946.489.5542.8481.14
Net Income
0.430.438.27-23.9271.6797.74
Earnings Per Share
---100.00-1200.00-2100.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3.973.974.625.5719.9838
Total Debt
1.071.070.361.17122.6987.81
Net Cash (Debt)
2.92.94.264.4-102.71-49.81
Net Cash Growth
9.39%-31.92%-3.07%---
Net Cash Per Share
0.920.923.4616.96-1666.53-1070.51

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.65-9.65-9.37-35.82-29.19-65.05
Capital Expenditures
-0.01-0.01-0.01-0.01-0.2-0.12
Free Cash Flow
-9.66-9.66-9.38-35.83-29.38-65.16
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
864.34%100.00%--46.06%42.39%
Operating Margin
2776.92%2776.92%--69.33%94.61%
Pretax Margin
2813.64%2813.64%--115.97%113.98%
Profit Margin
-2825.17%-2825.17%--115.97%113.98%
FCF Margin
-3376.22%-3376.22%---47.55%-75.98%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---0.37--
PS Ratio
12.5418.34--0.211.59